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Introduction
In 1985, North Carolina initiated a
human immunodeficiency virus (HIV)
counseling/testing program that, for 6
years, provided both anonymous and
confidential testing in all of the state's 100
counties. In anonymous testing, no link
between the person's name and test result
exists. In confidential testing, the individu-
al's name and HIV status are reported. In
1991, the North Carolina Commission for
Health Services, a body of lay and
professional persons appointed by the
governor and the state medical society,
voted to phase out anonymous testing.
After considerable public opposition, a
compromise was reached: beginning Sep-
tember 1, 1991, anonymous testing was
simultaneously discontinued in 82 coun-
ties but retained in 18; confidential testing
remained available statewide; and perma-
nent abolishment of anonymous testing
was contingent on evidence that the loss
of such testing would not adversely affect
HIV testing rates. On January 1, 1993,
anonymous testing resumed in all 100
counties by court order.
North Carolina was scheduled to
once again completely eliminate anony-
mous testing in 1996, but lawsuits have
prevented the implementation of this ac-
tion; the state's Supreme Court is reviewing
the case. This report assesses the impact of
North Carolina's 1991/92 restriction of
anonymous testing on HIV test-seeking.
Methods
HIV testing data from publicly
funded stand-alone counseling/testing
sites and from other public health clinics
in North Carolina were provided by the
state's Department of Environment,
Health, and Natural Resources. This
analysis covers May 1991 through Decem-
ber 1992 (4 months prior to and 16
months during restriction of anonymous
testing). Before May 1991, complete com-
puterized data were unavailable. Observa-
tions missing month or year of test were
eliminated. Persons tested more than
once could not be identified.
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Variables included individual, test,
and test-site characteristics. Individual
characteristics were age, race, gender,
reason for appearance at the site, insur-
ance status, and risk behaviors (see Tables
1 and 2). Behaviors were not mutually
exclusive: individuals could engage in
multiple risky behaviors. Test variables
were whether a test was declined (after
pretest counseling), whether it was anony-
mous or confidential, the result (positive,
negative, unknown, inconclusive), and
whether the client received the result.
One test-site characteristic was used:
whether or not the county offered anony-
mous testing during the restriction period
("county type"). The individual's county
of residence and the specific county in
which the test site was located were not
available.
We first compared the two county
types with respect to the proportion
declining a test and the characteristics of
those tested. Analyses excluded those
seeking treatment for sexually transmitted
diseases, tuberculosis, drug problems, and
so forth, since the focus was on the impact
of policy on individuals' test-seeking be-
havior rather than on physician practices.
Monthly public-sector testing rates, calcu-
lated with population denominators from
the 1990 census,1 were graphed to com-
pare 20-month time trends in the two
county types.
Quantitative comparison of trends
was based on the average monthly num-
ber of tests, calculated for each county
type separately. The prerestriction period
monthly average was subtracted from the
restriction period average to obtain per-
centage change. The percentage point
difference in temporal change was used to
compare the two county types.
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A seasonally adjusted analysis was
also conducted. The prerestriction months
(May through August 1991) were com-
pared with the same months in the
restriction period (May through August
1992). Similar comparisons could not be
made for other months because only 4
prerestriction months of data were avail-
able.
We further examined whether insur-
ance status (private, public, or none) was
associated with choosing an anonymous
or confidential test in counties offering
both. Finally, we assessed whether receipt
of test results was associated with test
type. HIV test results must be communi-
cated in person by a state worker.
Results
During the study period, an HIV test
was the recorded "reason for visit" for
71 434 appearances at testing sites. Of the
individuals included in this category, 253
were not tested, most (n = 238) simply
"declining" the test after receiving coun-
seling (no further information was avail-
able). Before restriction, those declining a
test were equally divided between the two
county types; during the restriction pe-
riod, however, three times as many de-
clined in counties offering only confiden-
tial testing as in counties offering both test
types (0.50% vs 0.16%). Thus, in counties
that eliminated anonymous testing, a
disproportionate number of persons de-
clined the test.
Descriptive data for those tested are
shown in Table 1. Women, African Ameri-
cans, and 18- to 34-year-olds were overrep-
resented relative to their proportions' in
North Carolina. Test seekers in the two
county types were similar. However, homo-
sexual and bisexual men accounted for a
higher percentage of tests in counties
retaining vs those eliminating anonymous
testing (10% vs 4%).
Data on insurance status were col-
lected only during the restriction period.
Test seekers in counties retaining anony-
mous testing included a higher proportion
with private or employer insurance than
those in other counties (36% vs 27%).
Changes in Test-Seeking over Time
Monthly testing increased through-
out the study period (Figure 1). However,
it increased more rapidly in counties that
retained anonymous testing. Table 2
shows monthly numbers of tests in the two
county types during the prerestriction and
restriction periods and during a seasonally
comparable restriction period, as well as
the percentage change with and without
seasonal adjustment. Differences be-
tween county types are shown in the last
two columns. Without adjustment for
seasonal trends, counties retaining anony-
mous testing had a 20 percentage point
greater increase in testing than counties
eliminating it (increase of 64% vs increase
of 44%). In each race or gender category,
testing increased more rapidly in counties
where anonymous testing was retained
(range of increase: 49% to 107%) than in
counties where it was not (28% to 58%).
A similar pattern was seen in every age
group: differences ranged from 4 to 61
percentage points. Two risk behavior
groups showed the inverse pattern of
smaller increases in counties that retained
anonymous testing: persons with a history
of sexually transmitted disease diagnosis




Seasonal adjustment magnified differ-
ences between the two county types.
Across all subgroups, testing in counties
retaining anonymous tests increased at a
rate that was 11 to 101 percentage points
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TABLE 1-HIV Testing at Publicly Funded Test Sites in North Carolina, May 1991
to December 1992
Counties with Counties with
Anonymous Testing Anonymous Testing
All Counties for 4 Months Only throughout Period
(No. Tests = (No. Tests = (No. Tests =
71 181),% 33069),% 38112),%
Gendera
Male 44.1 39.9 47.7
Female 55.6 59.7 52.0
Missing 0.3 0.4 0.3
Racea
White 64.8 65.2 64.5
African American 32.3 31.7 32.8
Other non-White 2.9 3.1 2.7
Missing < 0.01 < 0.01 0.01
Age, ya
12 and under 0.6 0.6 0.6
13-17 5.5 7.4 4.0
18-24 30.0 31.3 28.9
25-34 36.3 34.8 37.5
35-44 18.6 17.4 19.7
45+ 8.3 7.6 8.9
Missing 0.6 0.8 0.4
HIV risk factorsb
Sex with men (male 7.4 3.9 10.3
subjects)
Intravenous drug user 6.5 7.3 5.9
Sex partner is intrave- 10.2 11.2 9.3
nous drug user
Sex partner is HIV 3.4 2.6 4.1
positive
Sexually transmitted 21.7 20.6 22.7
disease diagnosis
since 1978
Sex for drugs or money 4.0 3.4 4.5
Health insurance statusa
None 27.2 28.0 26.5
Public 8.2 10.3 6.3
Private 31.3 26.5 35.5
Missingc 33.3c 35.2 31.7
Note. All values reported represent individuals whose "reason for visit" was an HIV test.
aColumn percentages sum to 100% for each category.
bNot all persons reported an HIV risk factor, and some reported more than one HIV risk factor;
hence, these column percentages do not sum to 100%.
cCollection of data on health insurance began during the restriction period; hence, most of those
missing this information were tested in the prerestriction period. During the period when this
information was collected, 3% of the subjects were missing.
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greater than the rate in counties eliminat-
ing them, with one exception: persons
with a history of sexually transmitted
disease diagnosis, for whom the increase
was smaller. In counties retaining the
anonymous option, testing more than
doubled for females, African Americans,
other non-Whites, 13- to 17-year-olds,
and 18- to 24-year-olds. Among homo-
sexual men and among intravenous drug
users, testing actually declined in counties
that eliminated anonymous tests.
Private Insurance
In counties offering a choice, persons
with private insurance were 2.9 times
more likely to choose an anonymous
rather than a confidential test (74% vs
26%). Those with public or no insurance
were slightly less likely to obtain an
anonymous test (46% vs 54%).
Receipt of Test Results
Most individuals received results at a
follow-up visit; a small percentage were
contacted by clinic workers or disease
intervention specialists. Persons tested
confidentially were more likely to not
receive their results than those tested
anonymously (21.3% vs 8.7%). Within
counties offering a choice, the figures
were 30.3% and 8.2%. Among persons
who tested positive, the percentages not
receiving results were nearly identical.
Discussion
The association between availability
of anonymous testing and a greater
increase in testing could be causal or
either partially or wholly due to unmea-
sured differences between the two types
of counties. Because the entire popula-
tion of tests in North Carolina, rather
than a random sample, was analyzed, the
results do not represent "chance" find-
ings.
Counties retaining anonymous test-
ing were more urban and had more
acquired immunodeficiency syndrome
(AIDS) cases2 than the other counties,
and hence residents probably were more
aware of the epidemic.3 Also, since dupli-
cate tests could not be identified, we could
not estimate the number of repeat tests or
determine whether they occurred more
frequently in counties offering anonymous
testing. National data indicate high rates
of repeat testing over a 5-year period.4
Our data did not permit examination of
either how frequently individuals crossed
county lines to obtain an anonymous test
or the extent to which persons provided
false names when getting a confidential
test. North Carolina does not require
proof of identification for persons tested
confidentially. At confidential test sites in
Colorado, 27% of test seekers admitted
they gave false identifying information.5
Circumstantial evidence from this
study supports a detrimental effect of
elimination ofanonymous testing.A higher
proportion of individuals declined a test
after pretest counseling at sites offering
only confidential testing, even though an
HIV test was the recorded reason for
their visit, and a lower proportion of
persons who were tested confidentially
received their results.
Persons with private health insur-
ance strongly preferred an anonymous
test. This finding is not surprising: confi-
dential positive HIV tests appear on
medical records, which are accessible by
court order and are routinely requested
for insurance and employment applica-
tions. Studies have shown that persons
with AIDS frequently lose their private
health insurance6 and/or are refused
treatment by health care providers.7 Also
given the importance of confidentiality as
a determinant of teens' behavior8 and the
rise in AIDS cases among adolescents
nationwide, the large differential between
adolescents in the two types of counties is
noteworthy.
Numerous studies suggest a link
between availability of anonymous testing
and test-seeking behavior and/or atti-
tudes,915 with high-risk groups particu-
larly reluctant to be tested confiden-
tially.5'812"l-21 Residents ofUS states that
restrict access to test results by employers
and insurers and that provide anonymous
testing are more likely to have been tested
than those living in states without such
policies.22
Those advocating elimination of
anonymous testing point out that confiden-
tial testing enables state agencies to
contact HIV-positive individuals regard-
ing partner notification. Many individuals
voluntarily notify sexual or needle con-
tacts, and some states legally require
HIV-infected individuals to do so. More-
over, two states23,24 have reported success-
ful partner notification programs when
index case patients are tested anony-
mously. Concerns have also been raised
about partner notification for female
index case patients in instances in which
there has been a history of domestic
violence.25 26 Indeed, partner notification
has led to physical abuse, abandonment,
and threats on these women's lives.2'27
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Note. Darkened circles represent counties that retained anonymous testing throughout the study
period; open circles represent counties that eliminated anonymous testing dunng the restriction
period; solid lines denote African Americans and other non-Whites combined; and dashed lines
denote Whites.
FIGURE 1 Population-based monthly rates of HIV testing at public-sector test
sites among those whose recorded reason for visit was an HIV test.
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TABLE 2-Average Number of HIV Tests per Month in North Carolina Counties, May 1991 to December 1992: Percentage
Change from Prerestriction to Restriction Period and Difference, by County Type
Counties with Anonymous Counties with Anonymous
Testing for 4 Months Only Testing throughout Period
Difference in %
Restriction Period Restriction Period Change between
Pre- Pre- Two County Types
restriction Full 16 Seasonally restriction Full 16 Seasonally
Period, Months, No. Adjusted, No. Period, Months, No. Adjusted, No. Fuli 16 Seasonally
No. (% Change) (% Change) No. (% Change) (% Change) Months Adjusted
Overall 1203 1736 (44.3) 1926 (60.1) 1246 2047 (64.3) 2371 (90.3) 20.0 30.2
Gender
Male 533 679 (27.5) 743 (39.5) 646 963 (49.1) 1111 (72.0) 21.6 32.5
Female 664 1051 (58.3) 1175 (77.0) 599 1078 (80.1) 1253 (109.3) 21.8 32.3
Race
White 791 1133 (43.3) 1236 (56.4) 827 1318 (59.4) 1458 (76.3) 16.2 19.9
African American 378 550 (45.3) 630 (66.5) 392 673 (71.8) 843 (115.2) 26.6 48.7
Other non- 34 54 (57.1) 61 (76.6) 27 56 (106.5) 70 (159.3) 49.4 82.6
White
Age,y
13-17 72 135 (87.5) 149 (108.0) 35 86 (148.6) 107 (208.7) 61.1 100.7
18-24 333 564 (69.3) 622 (86.5) 301 613 (104.0) 675 (124.5) 34.7 38.0
25-34 455 607 (33.5) 671 (47.6) 509 767 (50.6) 893 (75.4) 17.2 27.9
35-44 236 301 (27.5) 342 (44.7) 260 404 (55.5) 485 (86.6) 28.1 41.9
45+ 108 130 (20.9) 143 (33.3) 142 177 (25.1) 211 (48.9) 4.2 15.6
HIV risk factorsa
Sex with men 71 62 (-12.4) 65 (-9.1) 174 201 (15.4) 221 (27.0) 27.8 36.1
(male subjects)
Intravenous 122 119 (-3.1) 130 (6.5) 102 114 (12.7) 137 (35.2) 15.8 28.7
drug user
Sex partner is 155 191 (23.5) 203 (31.0) 128 188 (47.0) 224 (75.2) 23.6 44.2
intravenous
drug user
Sex partner is 39 44 (11.5) 48 (21.0) 55 84 (52.1) 98 (76.5) 40.7 55.5
HIV positive




Sexfordrugsor 46 59 (30.1) 60 (32.4) 78 86 (10.7) 112 (43.7) -19.4 11.3
money
Note. All values reported represent individuals whose "reason for visit" was an HIV test. Those 12 years of age or younger were excluded.
aThese categories were not mutually exclusive. Persons could be in more than one category or in none of the categories.
Between May 1991 and December
1992, HIV test-seeking at publicly funded
sites in North Carolina increased more
rapidly in counties that retained anony-
mous testing than in counties that elimi-
nated it. Seasonal adjustment magnified
the differences, particularly in some high-
risk groups: adolescents, African Ameri-
cans, other non-Whites, partners of intra-
venous drug users, and persons with
infected partners. Since counties were not
randomized, the disparity in testing trends
could be at least partly due to differences
in awareness about AIDS or in numbers
of repeat tests. Nevertheless, our data are
consistent with a detrimental effect of
elimination of anonymous testing, and
evidence from other studies supports this
conclusion. Clinicians referring patients
to public HIV test sites should be aware of
how testing options may affect test-
seeking behavior. Those making policy
decisions affecting the availability of
anonymous testing must take into account
possible consequences for high-risk and/or
vulnerable persons. O
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Alcohol and Drug Use, Abuse,
and Dependence among
Welfare Recipients
Bridget F. Grant, PhD, PhD, and DeborahA. Dawson, PhD
Introduction
The network of federal programs
designed to help the nation's needy has
rapidly grown since the Great Depres-
sion, most notably as the result of the War
on Poverty. Recent concerns regarding
these programs, referred to collectively as
welfare, have generated great debate in
the current administration and among
lawmakers. At the center of this often
intense and emotional political debate are
characterizations of welfare recipients
that are usually not supported by empiri-
cal data. One such characterization de-
picts the welfare mother in particular as
having an alcohol or drug problem. It was
the objective of the present study to
provide the most recent national esti-
mates of the prevalence of heavy alcohol
use, drug use, and alcohol and drug abuse
and dependence among welfare recipi-
ents participating in five social services
programs: Aid to Families with Depen-
dent Children (AFDC); the Special
Supplemental Food Program for Women,
Infants, and Children (WIC); food stamps;
supplemental security income (SSI); and
Medicaid. The major goal of the study was
to identify high-risk subgroups of the
welfare population in need of prevention,
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